中药“参阳”方辅助治疗口腔鳞癌对机体免疫功能的影响

Effect of chinese traditional prescription 《Shen Yang》on the immune function of oral squamous cells carcinoma patients.

作者给２３８例口腔鳞癌病员术后服用中药“参阳”方或对照Ｃ方观察两组不同治疗方法对患者免疫功能的影响进行了前瞻性的研究，研究按随机分组原则给药，以ＤＮＣＢ皮试法为观察指标。结果：服药３个月后，＂参阳＂方组的ＤＮＣＢ阳性率比Ｃ方有明显增加（Ｐ＜０。０５），６个月后，进一步增加（Ｐ＜０．０１），１年以上，则两组病员的ＤＮＣＢ反应用性率均明显增加。研究提示：参阳方能提高口腔鳞癌病员术后的免疫机能。

This report tries to compare the immunologic function of being take the chinese medicine 'Fu-Fang Shen Yang'or placebo C which is based on randomized clinical traials after operation for 238 cases of oral squamous cancer. DNCB test is for observable index. The results as follows: DNCB position rate of 1 《Shen Yang》group is significantly increased to compare with the placebo C group ,after 3m(p <0. o1) 6m (P<0. 001 ). Two groups are significantly increased after one year. This suggestion that 'Fu-Fang Shen Yang' can enhance immunologic function after operation for oral squamous cells carcinoma patients.